(Q26777479)

Anais Brasileiros de Dermatologia

published in

4 references

12 March 2019

3 April 2019

17 June 2019

90

0 references

page(s)

687-706

0 references

issue

5

0 references

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

3 references

Europe PubMed Central

12 March 2019

Europe PubMed Central

3 April 2019

Europe PubMed Central

on focus list of Wikimedia project

17 June 2019

ScienceSource

0 references

cites work

Lymphomatoid granulomatosis

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

A Case of Cutaneous Plasmablastic Lymphoma in HIV/AIDS with Disseminated Cryptococcus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Clonality assessment of cutaneous B-cell lymphoid proliferations: a comparison of flow cytometry immunophenotyping, molecular studies, and immunohistochemistry/in situ hybridization and review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Extramedullary chronic lymphocytic leukemia: systematic analysis of cases reported between 1975 and 2012.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Rituximab in the treatment of primary cutaneous B-cell lymphoma: a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Cutaneous B-cell lymphoproliferative disorders: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Cutaneous plasmablastic lymphoma in an immunocompetent patient with long-term pyrimethamine use for essential thrombocythemia: a case report and literature review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomas

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Focal rituximab-induced edematous reaction at primary cutaneous follicle center lymphoma lesions: case report and literature review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Plasmablastic lymphoma and related disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Cutaneous T-cell/histiocyte-rich B-cell lymphoma: a case report and review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

The hand-foot-syndrome associated with medical tumor therapy - classification and management

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Primary cutaneous marginal zone lymphoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Primary cutaneous T-cell-rich B-cell lymphoma: a case report and literature review.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

HIV-associated lymphomas and gamma-herpesviruses.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Cutaneous B-cell lymphoma responds to rituximab: a report of five cases and a review of the literature.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Skin manifestation of mantle cell lymphoma.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

A review of rituximab in cutaneous medicine

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Standard and new treatments in cutaneous B-cell lymphomas

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

WHO-EORTC classification for cutaneous lymphomas

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Therapy of cutaneous lymphoma--current practice and future developments

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Gene Expression Profiles of Cutaneous B Cell Lymphoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Stevens-Johnson syndrome after treatment with rituximab

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

The skin-associated lymphoid tissue-related B-cell lymphomas

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Angiotropic lymphoma: proliferation of B cells in the capillaries of cutaneous angiomas

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Primary cutaneous follicle center cell lymphoma with follicular growth pattern.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Mechanisms of interferon-induced cell cycle arrest

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Follicular spicules of the nose: a peculiar cutaneous manifestation of multiple myeloma with cryoglobulinemia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Reticulohistiocytoma of the dorsum.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Hepatitis C and G viruses in B-cell lymphomas of the skin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Complete response of a primary cutaneous T-cell-rich B cell lymphoma treated with interferon alpha2a.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extra-nodal sites.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Pathogenesis of paraneoplastic follicular hyperkeratotic spicules in multiple myeloma. Follicular and epidermal accumulation of IgG dysprotein and cryoglobulin

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Primary cutaneous B-cell lymphomas: part II. Therapy and future directions

31 May 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

B-cell lymphomas involving the skin associated with hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Analysis of immunoglobulin V genes suggests cutaneous marginal zone B-cell lymphomas recognise similar antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Primary cutaneous Epstein-Barr virus-associated B-cell lymphoma arising at the site of subcutaneous injections of methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Cytogenetic and molecular analysis of 12 cases of primary cutaneous marginal zone lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycos

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Anetoderma arising in cutaneous B-cell lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Anetodermic primary cutaneous B-cell lymphoma: a unique clinicopathological presentation of lymphoma possibly associated with antiphospholipid antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Plasmablastic lymphoma: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Cutaneous plasmablastic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Epstein-Barr virus- and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Primary cutaneous plasmablastic lymphoma in an immunocompetent patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Cutaneous plasmablastic lymphoma in a nonimmunocompromised patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Long-term outcome of intravenous therapy with rituximab in patients with primary cutaneous B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Treatment of primary cutaneous follicular centre lymphoma with rituximab: a report of two cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Red nose: primary cutaneous marginal zone B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Primary cutaneous follicle center lymphoma responsive to interferon alfa-2a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Intravascular Large Cell Lymphoma Coexisting Within Hemangiomas of the Skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Primary Cutaneous B-Cell Lymphoma Treated With Radiotherapy: A Comparison of the European Organization for Research and Treatment of Cancer and the WHO Classification Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Plasmablastic lymphoma arising at a cutaneous site

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

Cutaneous macroglobulinosis with monotypic plasma cells: a specific manifestation of Waldenström macroglobulinemia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Intralesional corticosteroid therapy for primary cutaneous B-cell lymphoma

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Skin problems associated with pegylated liposomal doxorubicin-more than palmoplantar erythrodysesthesia syndrome.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Cutaneous nodules as diagnostic key of an extraoral plasmablastic lymphoma in an human immunodeficiency virus-infected patient

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4631235

Array-Based Comparative Genomic Hybridization Analysis Reveals Recurrent Chromosomal Alterations and Prognostic Parameters in Primary Cutaneous Large B-Cell Lymphoma

28 November 2018

1 reference

https://api.crossref.org/works/10.1590%2FABD1806-4841.20153638

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of

21 January 2018

1 reference

12 December 2020

Letter: Primary cutaneous marginal zone B cell lymphoma of the face: a challenging diagnosis

1 reference

12 December 2020

Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases

1 reference

12 December 2020

Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association

1 reference

12 December 2020

Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment

1 reference

12 December 2020

Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma

1 reference

12 December 2020

Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma

1 reference

12 December 2020

Reversible cutaneous lymphoma occurring during methotrexate therapy

1 reference

12 December 2020

Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma

1 reference

12 December 2020

Primary cutaneous T-cell-rich B-cell lymphoma. A case report with a 13-year follow-up

1 reference

12 December 2020

Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling

1 reference

12 December 2020

[Plasmablastic lymphoma in a patient with HIV infection: an unusual case located in the skin]

1 reference

12 December 2020

Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients

1 reference

12 December 2020

Borrelia burgdorferi-associated primary cutaneous marginal-zone B-cell lymphoma: a case report

1 reference

12 December 2020

Radiotherapy in the management of cutaneous B-cell lymphoma. Our experience in 25 cases

1 reference

12 December 2020

Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab

1 reference

12 December 2020

Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma

1 reference

12 December 2020

Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis

1 reference

12 December 2020

Patterns of cutaneous lymphomas. Histological, enzyme cytochemical, and immunological typing of lymphoreticular proliferations in the skin

1 reference

12 December 2020

T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma

1 reference

12 December 2020

M protein deposition in the skin: a rare manifestation of Waldenström macroglobulinemia

1 reference

12 December 2020

Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients

1 reference

12 December 2020

[Cutaneous follicular center B-cell lymphoma treated with intralesional rituximab]

1 reference

12 December 2020

Semimalignant ("pseudolymphomatous") cutaneous B-cell lymphomas

1 reference

12 December 2020

Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas

1 reference

12 December 2020

CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: diagnostic and pathogenetic implications

1 reference

12 December 2020

Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France

1 reference

12 December 2020

Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases

1 reference

12 December 2020

Primary cutaneous marginal center lymphoma - complete remission induced by interferon alpha2a

1 reference

12 December 2020

Complement activation plays a key role in the side-effects of rituximab treatment

1 reference

12 December 2020

Systemic rituximab in multifocal primary cutaneous follicle centre lymphoma

1 reference

12 December 2020

Anetoderma in cutaneous marginal-zone B-cell lymphoma

1 reference

12 December 2020

Clinical study of primary cutaneous B-cell lymphoma using both the European Organization for Research and Treatment of Cancer and World Health Organization classifications

1 reference

12 December 2020

Differentiation between lymphadenosis benigna cutis and primary cutaneous follicular center cell lymphomas. A comparative clinicopathologic study of 57 patients

1 reference

12 December 2020

Primary cutaneous CD30+ large cell B-cell lymphoma: a series of 10 cases

1 reference

12 December 2020

Intralesional rituximab for cutaneous B-cell lymphoma

1 reference

12 December 2020

Flow cytometry of lesional skin enhances the evaluation of cutaneous B-cell lymphomas

1 reference

12 December 2020

Rituximab for primary cutaneous diffuse large B-cell lymphoma-leg type

1 reference

12 December 2020

Multiple hyperkeratotic spicules and myeloma

1 reference

12 December 2020

FISH analysis of MALT lymphoma-specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma

1 reference

12 December 2020

Extranodal marginal zone B-cell lymphoma of the skin: a morphologic and immunophenotypic study of 11 cases

1 reference

12 December 2020

Cutaneous nodules as a diagnostic clue in multiple myeloma

1 reference

12 December 2020

Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases

1 reference

12 December 2020

Rituximab in cutaneous B-cell lymphoma: a report of two cases

1 reference

12 December 2020

1 reference

12 December 2020

"Skin problems associated with pegylated liposomal doxorubicin -- more than palmoplantar erythrodysesthesia syndrome"

1 reference

12 December 2020

Treatment of primary cutaneous B-cell lymphoma with rituximab

1 reference

12 December 2020

Malignant angioendotheliomatosis is an angiotropic intravascular lymphoma. Immunohistochemical, ultrastructural, and molecular genetics studies

1 reference

12 December 2020

Subclinical chronic lymphocytic leukemia with atypical cutaneous presentation

1 reference

12 December 2020

Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas

1 reference

12 December 2020

Complete remission following recombinant interferon alpha-2a in a patient with diffuse large B cell cutaneous lymphoma

1 reference

12 December 2020

Unusual cutaneous manifestations of B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Primary cutaneous plasmablastic lymphoma of the lower leg in an HIV-negative patient

1 reference

12 December 2020

Dermatologic radiotherapy of primary cutaneous follicle center cell lymphoma

1 reference

12 December 2020

Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification

1 reference

12 December 2020

Cutaneous marginal zone B-cell lymphoma: A case accompanied by massive plasmacytoid cells

1 reference

12 December 2020

Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a

1 reference

12 December 2020

[Anti-CD20 antibodies in primary cutaneous B-cell lymphoma. Initial results in dermatologic patients]

1 reference

12 December 2020

Primary cutaneous marginal zone B-cell lymphoma with anetoderma: spontaneous involution plus de novo clonal expansion

1 reference

12 December 2020

Radiotherapy in the treatment of dermatologic malignancies

1 reference

12 December 2020

Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases

1 reference

12 December 2020

Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody

1 reference

12 December 2020

Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma

1 reference

12 December 2020

Molecular analysis of the immunoglobulin heavy chain gene in the diagnosis of primary cutaneous B cell lymphoma

1 reference

12 December 2020

Cutaneous involvement by Burkitt lymphoma

1 reference

12 December 2020

Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma

1 reference

12 December 2020